Hcw Biologics earnings were -$30.0M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest HCWB earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.4M, down 13.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, HCWB reported annual earnings of -$30.0M, with 20.1% growth.
Hcw Biologics (NASDAQ: HCWB) reported Q4 2024 earnings per share (EPS) of -$2.40, up 80% year over year. Total HCWB earnings for the quarter were -$3.37 million. In the same quarter last year, Hcw Biologics's earnings per share (EPS) was -$12.00.
As of the last Hcw Biologics earnings report, Hcw Biologics is currently losing money. Hcw Biologics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$30.02 million, a 20.12% increase year over year.
What was HCWB's earnings growth in the past year?
As of Hcw Biologics's earnings date in Q2 2025, Hcw Biologics's earnings has grown year over year. HCWB earnings in the past year totalled -$30.02 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.